Roche Cut to Sell as US Investment Bank Warns of Downside to Consensus Estimates
Morgan Stanley downgraded Roche (SWX: ROG) to “Underweight” from “Equal Weight” in a note Friday, cutting its price target to $39 from $44. The bank cited weaker prospects…


















